David J Werring Selected Research

Hypertension (High Blood Pressure)

4/2024	Statin Therapy for Secondary Prevention in Ischemic Stroke Patients With Cerebral Microbleeds.
8/2022	Intracranial Aneurysm Classifier Using Phenotypic Factors: An International Pooled Analysis.
1/2022	New Insights Into Cerebrovascular Pathophysiology and Hypertension.
1/2018	Total Small Vessel Disease Score in Neurologically Healthy Japanese Adults in the Kashima Scan Study.
4/2017	MRI-visible perivascular space location is associated with Alzheimer's disease independently of amyloid burden.
1/2016	Volume and functional outcome of intracerebral hemorrhage according to oral anticoagulant type.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David J Werring Research Topics

Disease

45	Ischemic Stroke 04/2024 - 01/2012
43	Stroke (Strokes) 04/2024 - 10/2004
25	Atrial Fibrillation 04/2024 - 01/2012
25	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2024 - 02/2012
21	Cognitive Dysfunction 10/2023 - 10/2004
20	Cerebral Hemorrhage 01/2024 - 06/2010
15	Cerebral Small Vessel Diseases 01/2023 - 02/2012
14	Hemorrhage 01/2024 - 10/2014
12	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 05/2013
8	Siderosis 01/2023 - 10/2014
7	Hematoma 04/2024 - 05/2017
6	Hypertension (High Blood Pressure) 04/2024 - 01/2016
6	Intracranial Hemorrhages (Intracranial Hemorrhage) 04/2024 - 02/2015
6	Dementia (Dementias) 01/2024 - 01/2016
5	Transient Ischemic Attack 04/2024 - 10/2015
5	COVID-19 01/2022 - 10/2020
4	Inflammation (Inflammations) 01/2023 - 01/2019
3	Leukoencephalopathies 12/2022 - 01/2015
3	Rupture 08/2022 - 01/2018
3	Intracranial Aneurysm (Cerebral Aneurysm) 01/2021 - 06/2018
3	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2020 - 11/2013
2	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 01/2024 - 01/2019
2	Edema (Dropsy) 01/2024 - 01/2019
2	Thromboembolism 10/2023 - 09/2019
2	Thrombosis (Thrombus) 10/2023 - 06/2023
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 10/2023 - 12/2021
2	Venous Thromboembolism 06/2023 - 09/2021
2	Seizures (Absence Seizure) 01/2023 - 11/2018
2	Brain Diseases (Brain Disorder) 01/2023 - 01/2021
2	Brain Injuries (Brain Injury) 01/2023 - 06/2014
2	Lacunar Stroke 01/2023 - 11/2013
2	Ischemia 01/2023 - 04/2014
2	Infarction (Infarctions) 01/2022 - 01/2021
2	Thrombocytopenia (Thrombopenia) 11/2021 - 01/2021
2	Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis) 09/2021 - 01/2021
2	Guillain-Barre Syndrome 01/2021 - 10/2020
2	Fabry Disease (Fabry's Disease) 12/2020 - 03/2014
2	Language Development Disorders (Semantic-Pragmatic Disorder) 01/2019 - 06/2017
2	Hearing Loss (Hearing Impairment) 01/2019 - 06/2017
2	Disease Progression 06/2017 - 01/2016
1	Patent Foramen Ovale 10/2023
1	Intracranial Thrombosis (Cerebral Thrombosis) 06/2023
1	Insulin Resistance 05/2023
1	Aphasia (Dysphasia) 02/2023
1	Carotid Artery Diseases 01/2023
1	Headache (Headaches) 01/2023
1	Bladder Exstrophy (Exstrophy, Bladder) 11/2022

Drug/Important Bio-Agent (IBA)

33	AnticoagulantsIBA 04/2024 - 01/2012
22	Biomarkers (Surrogate Marker)IBA 01/2024 - 06/2014
22	Amyloid (Amyloid Fibrils)IBA 01/2023 - 02/2012
12	Vitamin K FDA Link 10/2023 - 09/2014
9	Tissue Plasminogen Activator (Alteplase)FDA Link 05/2023 - 06/2014
6	Amyloid beta-PeptidesIBA 01/2024 - 11/2013
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2024 - 11/2011
4	ORALIT (ORS)IBA 01/2022 - 08/2017
4	N(4)-oleylcytosine arabinosideIBA 11/2018 - 09/2015
4	ApolipoproteinsIBA 04/2017 - 11/2013
3	Tenecteplase FDA Link 02/2023 - 10/2021
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2023 - 09/2014
3	Proteins (Proteins, Gene)FDA Link 11/2022 - 01/2015
3	Apolipoproteins E (ApoE)IBA 09/2022 - 11/2013
3	Tranexamic Acid (AMCA)FDA Link 01/2022 - 01/2021
3	fibrin fragment D (D-dimer)IBA 01/2022 - 01/2021
3	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 06/2015 - 01/2014
3	5- aminocarbonyl- 10,11- dihydro- 5H- dibenzo(a,d)cyclohepten- 5,10- imine (ADCI)IBA 02/2015 - 05/2013
2	PrionsIBA 01/2024 - 01/2019
2	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 05/2023
2	Antiphospholipid AntibodiesIBA 10/2023 - 09/2021
2	Warfarin (Coumadin)FDA LinkGeneric 01/2023 - 01/2016
2	IronIBA 07/2022 - 03/2022
2	AntibodiesIBA 12/2021 - 01/2021
2	Immunoglobulin G (IgG)IBA 12/2021 - 09/2021
2	VaccinesIBA 11/2021 - 01/2021
2	Anticonvulsants (Antiepileptic Drugs)IBA 12/2020 - 11/2018
2	Antihypertensive Agents (Antihypertensives)IBA 01/2018 - 10/2004
2	Apolipoprotein E4IBA 05/2014 - 11/2013
1	Factor XI (Plasma Thromboplastin Antecedent)IBA 04/2024
1	Growth Hormone (Somatotropin)IBA 01/2024
1	C-Reactive ProteinIBA 01/2024
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 10/2023
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 10/2023
1	Blood Coagulation Factors (Coagulation Factor)IBA 06/2023
1	Triglycerides (Triacylglycerol)IBA 05/2023
1	CI 22IBA 01/2023
1	isosorbide-5-mononitrate (Ismo)FDA LinkGeneric 01/2023
1	Cilostazol (Pletal)FDA LinkGeneric 01/2023
1	Genetic Markers (Genetic Marker)IBA 01/2023
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2023
1	GadoliniumIBA 01/2023
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2023
1	Cathepsin AIBA 12/2022
1	Ephrin-A1 (Ephrin A1)IBA 11/2022

Therapy/Procedure

27	Therapeutics 04/2024 - 04/2013
9	Secondary Prevention 04/2024 - 09/2014
4	Thrombectomy 01/2023 - 08/2017
3	Immunotherapy 10/2020 - 01/2015
2	Contraindications 01/2023 - 06/2010
2	Continuous Ambulatory Peritoneal Dialysis (CAPD) 01/2019 - 06/2017
1	Craniotomy 04/2024
1	Precision Medicine 01/2023